Masimo (MASI) Other Non-Current Liabilities (2010 - 2026)
Masimo's (MASI) quarterly Other Non-Current Liabilities came in at $82.3 million in Q2 2026, up 12.28% year-on-year from $73.3 million in Q2 2025, and down 6.26% quarter-over-quarter from $87.8 million in Q1 2026.
Masimo (MASI) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Masimo's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $82.3 million for Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 12.28% year-over-year to $82.3 million in Q2 2026; TTM through Apr 2026 was $82.3 million, a 12.28% increase from a year earlier, with the FY2026 full-year figure at $87.8 million, up 23.84% from the prior year.
- Other Non-Current Liabilities eased to $82.3 million in Q2 2026 per MASI's latest filing, from $87.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $284.0 million in Q3 2022 and bottomed at $64.0 million in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $121.3 million (2023), against an average of $115.2 million.
- Across the five-year window, Other Non-Current Liabilities soared 303.27% in 2022 and tumbled 56.58% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $136.5 million in 2022, then declined by 5.13% to $129.5 million in 2023, then tumbled by 45.25% to $70.9 million in 2024, then rose by 10.86% to $78.6 million in 2025, then advanced by 4.71% to $82.3 million in 2026.
- Per Business Quant, the three latest MASI Other Non-Current Liabilities figures stand at $82.3 million (Q2 2026), $87.8 million (Q1 2026), and $78.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 82.30 Mn |
| Jan 3, 2026 | 87.80 Mn |
| Sep 27, 2025 | 78.60 Mn |
| Jun 28, 2025 | 76.30 Mn |
| Mar 29, 2025 | 73.30 Mn |
| Dec 28, 2024 | 70.90 Mn |
| Sep 28, 2024 | 142.50 Mn |
| Jun 29, 2024 | 130.30 Mn |
| Mar 30, 2024 | 140.00 Mn |
| Dec 30, 2023 | 129.50 Mn |
| Sep 30, 2023 | 119.30 Mn |
| Jul 1, 2023 | 123.30 Mn |
| Apr 1, 2023 | 136.10 Mn |
| Dec 31, 2022 | 136.50 Mn |
| Oct 1, 2022 | 125.90 Mn |
| Jul 2, 2022 | 284.00 Mn |
| Apr 2, 2022 | 72.35 Mn |
| Jan 1, 2022 | 64.00 Mn |
| Oct 2, 2021 | 70.38 Mn |
| Jul 3, 2021 | 70.42 Mn |